Back

dr. J.F. Swart

dr. J.F. Swart

Assistant Professor - medical
dr. J.F. Swart
  • Immunology patient care

Research Programs

Child Health

Biography

Biography

Joost Swart is a board certified paediatrician immunologist & rheumatologist. After receiving his Medical Degree (cum laude/ with Honour) from the University of Groningen in 1999, he finished his training as a paediatrician at the VU Medical Center in Amsterdam in 2006. His fellowship paediatric rheumatology-immunology was completed in 2008 in Utrecht. He worked as a paediatric rheumatologist for 3 years in both Reade and the VUmc in Amsterdam. In 2011 he came to work in the largest Dutch group of Pediatric Rheumatology / Immunology based in Utrecht. He is currently doing a Master in Epidemiology at Utrecht University.

His research (and that of his PhD-students) focuses on comparative effectiveness and safety of drugs, treatment-strategies and eHealth in juvenile idiopathic arthritis (JIA). He also analysed the effects of mesenchymal stem cells in JIA-patients. Furthermore he is researcher and member of the Steering Committee of the international Pharmacovigilance database Pharmachild (over 9000 JIA-patients who have contributed their clinical data and thousands of blood and synovial samples) and is co-P.I. of the UCAN CAN-DU project (JIA project involving all academic paediatric rheumatology centers in the Netherlands and Canada). https://www.ucancandu.com/

He is (co-)author on more than 60 scientific articles in peer-reviewed journals, mostly related to JIA. He is (co-)applicant on multiple successful research grants (e.g. UCAN CAN-DU. Real-life integration of innovative precision medicine strategies into care provision will forever transform the care of children with arthritis in our countries and beyond. Canadian Institutes of Health Research/ The Netherlands Organisation for Health Research and Development [ZonMw]/ Dutch Arthritis Foundation funded  €5,500,000).

He is council member of the Dutch Association for Paediatric Rheumatology, council member of the Pediatric Rheumatology International Trial Organization and chair of the Pharmacovigilance and Targeted Therapies Working Party of ERN-RITA. He is member of the Dutch Pediatric Association, Dutch Rheumatology Association, Paediatric Rheumatology European Society, and the Dutch Association against Quackery.

He educates students in both the CRU and Summa medical curricula in Utrecht. He trains interns, residents and fellows in paediatrics and rheumatology in UMC Utrecht. He is a certified instructor on the APLS-course from the Advance Life Support Group.

Side Activities

-Chair of Pharmacovigilance Working Party, European Reference Network, Rare Immunodeficiencies, AutoImmune and AutoInflammatory Diseases (ERN RITA)

-Co-chair of Clinical Guidelines Working Party, ERN RITA

-Council Member for the Paediatric Rheumatology International Trials Organisation (PRINTO)

Board member of the Dutch Pediatric Rheumatology Association

-National coordinator Pediatric Rheumatology International Trials Organization (Printo)

-Member of the European Medicines Agency (EMA) Working Party with Healthcare Professionals on behalf of European League against Rheumatism (EULAR)

-Member of JIA Working Group of Outcome Measures in Rheumatology (OMERACT)

-Member of the SHARE initiative European consensus-based recommendations for

the diagnosis and treatment of JIA

-Member of Digital Health Working Party of Dutch Rheumatology Association (NVR)

-Member of Steering Committee of UCAN CAN-DU

-Member of Steering Committee of PharmaChild

-Member of Data Safety Monitoring Board STARS Trial (PRINTO study with PI: Dr Consolaro)

-Member of Digital Health Working Party of Dutch Rheumatology Association (NVR)

-Utrecht representative of Dutch Paediatric Clinical Trial Network (Pedmed-NL) 

 

Fellowship and Awards

2015                            “The Addition of one or more Biologics to Methotrexate in Children with JIA increases the Incidence of

                                   Infections and Serious Adverse Events. The 5882 Pharmachild Cohort.” Selected as Top 6 of Clinical

                                   Science Abstracts chosen from 4323 Abstracts EULAR Congress Rome

2010                            “Mesenchymal Stem Cell Therapy has significant Clinical and Histopathological Effect in Proteoglycan

                                    Induced Arthritis” Selected as Top 25 of Basic Science Abstracts chosen from 3,508 Abstracts EULAR

                                    Congress Rome

2009                            Teaching Award for Excellence in Clinical Teaching, Dep. of Paediatrics, VUmc Amsterdam

2002                            Resident Teaching Award for Excellence in Clinical Teaching, Dep. of Paediatrics,

                                    Deventer Hospitals, NL

Research Output (93)

Association of adalimumab trough concentrations and treatment response in patients with juvenile idiopathic arthritis

Doeleman Martijn J H, de Roock Sytze, El Amrani Mohsin, van Maarseveen Erik M, Wulffraat Nico M, Swart Joost F 24 Dec 2021, In: Rheumatology (Oxford, England). 61 , p. 377-382 6 p.

Genomic Health Literacy Interventions in Pediatrics:Scoping Review

Gupta Aarushi, Cafazzo Joseph A., IJzerman Maarten J., Swart Joost F., Vastert Sebastiaan, Wulffraat Nico M., Benseler Susanne, Marshall Deborah, Yeung Rae, Twilt Marinka Dec 2021, In: Journal of Medical Internet Research. 23

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis

Trincianti Chiara, Van Dijkhuizen Evert Hendrik Pieter, Alongi Alessandra, Mazzoni Marta, Swart Joost F., Nikishina Irina, Lahdenne Pekka, Rutkowska-Sak Lidia, Avcin Tadej, Quartier Pierre, Panaviene Violeta, Uziel Yosef, Pruunsild Chris, Vargova Veronika, Vilaiyuk Soamarat, Dolezalova Pavla, Ringold Sarah, Garrone Marco, Ruperto Nicolino, Ravelli Angelo, Consolaro Alessandro, Nov 2021, In: Arthritis and Rheumatology. 73 , p. 1966-1975 10 p.

Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis:A Canadian Retrospective Cohort Study

Grazziotin Luiza R., Currie Gillian, Twilt Marinka, Ijzerman Maarten J., Kip Michelle M.A., Koffijberg Hendrik, Benseler Susanne M., Swart Joost F., Vastert Sebastiaan J., Wulffraat Nico M., Yeung Rae S.M., Johnson Nicole, Luca Nadia J., Miettunen Paivi M., Schmeling Heinrike, Marshall Deborah A., Sep 2021, In: Rheumatology and therapy. 8 , p. 1303-1322 20 p.

Internet and smartphone-based ecological momentary assessment and personalized advice (PROfeel) in adolescents with chronic conditions:A feasibility study

Nap-van der Vlist Merel M., Houtveen Jan, Dalmeijer Geertje W., Grootenhuis Martha A., van der Ent Cornelis K., van Grotel Martine, Swart Joost F., van Montfrans Joris M., van de Putte Elise M., Nijhof Sanne L. Sep 2021, In: Internet Interventions. 25 , p. 1-10

Parent-Child Dyadic Coping and Quality of Life in Chronically Diseased Children

Nap-van der Vlist Merel M., van der Wal Reine C., Grosfeld Eva, van de Putte Elise M., Dalmeijer Geertje W., Grootenhuis Martha A., van der Ent Cornelis K., van den Heuvel-Eibrink Marry M., Swart Joost F., Bodenmann Guy, Finkenauer Catrin, Nijhof Sanne L. 28 Jul 2021, In: Frontiers in Psychology. 12

Role of parents in fatigue of children with a chronic disease:A cross-sectional study

Kramer Niels, Nijhof Sanne L., Van De Putte Elise M., Ketelaar Marjolijn, Grootenhuis Martha A., Van Der Ent Kors, Swart Joost F., Van Grotel Martine, Dalmeijer Geertje W., Nap-Van Der Vlist Merel M. 21 May 2021, In: BMJ paediatrics open. 5 , p. 1-9

Daily life participation in childhood chronic disease:A qualitative study on the child's and parent's perspective

Nap-Van Der Vlist Merel M., Berkelbach Van Der Sprenkel Emma E., Nijhof Linde N., Grootenhuis Martha A., Van Der Ent Cornelis K., Swart Joost F., Van Royen-Kerkhof Annet, Van Grotel Martine, Van De Putte Elise M., Nijhof Sanne L., Kars Marijke C. 18 May 2021, In: BMJ paediatrics open. 5 , p. 1-9

Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritis

Verwoerd Anouk, Armbrust Wineke, Cowan Katherine, van den Berg Lotte, de Boer Joke, Bookelman Sanne, Britstra Marjan, Cappon Jeannette, Certan Maria, Dedding Christine, van den Haspel Karin, Muller Petra Hissink, Jongsma Karin, Lelieveld Otto, van Loosdregt Jorg, Olsder Wendy, Rocha Johanna, Schatorjé Ellen, Schouten Natasja, Swart Joost F., Vastert Sebastiaan, Walter Margot, Schoemaker Casper G. 7 Apr 2021, In: Pediatric Rheumatology. 19

Monitoring patients with juvenile idiopathic arthritis using health-related quality of life

Doeleman Martijn J.H., de Roock Sytze, Buijsse Nathan, Klein Mark, Bonsel Gouke J., Seyfert-Margolis Vicki, Swart Joost F., Wulffraat Nico M. 22 Mar 2021, In: Pediatric Rheumatology. 19 , p. 40

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet